View of Genetic Polymorphism Of Cyp3A5 As A Key Regulator Of Pharmacokinetics Of Tacrolimus In Kidney Transplant Patients: Evidence In Kazakh Population

Return to Issue Details Genetic Polymorphism Of Cyp3A5 As A Key Regulator Of Pharmacokinetics Of Tacrolimus In Kidney Transplant Patients: Evidence In Kazakh Population Download Download PDF